stella
beta
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM — Stella
Home
/
Arrhythmogenic Cardiomyopathy
/
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
View on ClinicalTrials.gov
Recruiting
Back to Arrhythmogenic Cardiomyopathy trials
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
Trial locations
(6 sites)
United States
Leland Stanford Junior University, Redwood City, California
Johns Hopkins University, Baltimore, Maryland
Northshore University Healthsystem Research Institute, Columbia, Maryland
University of Michigan, Ann Arbor, Michigan
Henry Ford Hospital, Detroit, Michigan
University of Rochester, Rochester, New York